Therefore, elevated parameters such as anti-Ro/SSA and anti-RNP antibodies, positive rheumatoid factor, and hypergammaglobulinemia may be markers for the development and progression of pSS-PAH [87]. The gene discussed is RNPC3; the disease is pulmonary arterial hypertension.